공시 • Mar 26
Forward Science Corp., Annual General Meeting, Jun 15, 2026 Forward Science Corp., Annual General Meeting, Jun 15, 2026. Location: no,6, yu yueh st., toufen city, miaoli county Taiwan New Risk • Jan 14
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 33% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (33% average weekly change). Minor Risk Market cap is less than US$100m (NT$1.18b market cap, or US$37.4m). New Risk • May 27
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risks Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (NT$565.8m market cap, or US$18.8m). 공시 • Mar 05
Forward Science Corp., Annual General Meeting, May 20, 2025 Forward Science Corp., Annual General Meeting, May 20, 2025. Location: no,6, yu yueh st., toufen city, miaoli county Taiwan New Risk • Jan 18
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (7.9% average weekly change). Minor Risk Market cap is less than US$100m (NT$811.1m market cap, or US$24.7m). New Risk • Jun 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Market cap is less than US$100m (NT$1.11b market cap, or US$34.2m). 공시 • Mar 13
Forward Science Corp., Annual General Meeting, May 27, 2024 Forward Science Corp., Annual General Meeting, May 27, 2024. 공시 • Dec 21
Forward Science Launches BioStom to Fight the Dental Opioid Epidemic Forward Science has officially released BioStom, the newest product in the Professional Use Product Line. BioStom is a non-opioid oral pain relief gel. This all-natural, oral wound dressing is now available to clinical professionals as of December 2021. With the recent concerns surrounding opioid prescription in the dental industry, Forward Science has been working on a non-drug option to manage oral pain, and BioStomTM will do just that. Studies show that dentists and oral surgeons are by far the majority of prescribers for opioids to people ages 10-19. This is a critical age range in which the still developing brain is particularly susceptible to addiction. BioStom Oral Pain Gel manages the pain of oral wounds, mouth sores, injuries and ulcers of the oral mucosa. It adheres to the oral tissue and forms a protective barrier between the wound and further prevents irritation and contamination. BioStom Oral Pain Gel also maintains a moist wound environment.